Directory
>
Caitlin Mevorach Cooper
Caitlin Mevorach Cooper
VP, Head of Business Development | Generation Bio
Boston, Massachusetts, United States
Caitlin Mevorach Cooper
Summary
Caitlin Mevorach Cooper is a seasoned business development professional with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as VP and Head of Business Development at Generation Bio, she has a proven track record in strategic business initiatives, financial analysis, and product management. Caitlin's career includes significant roles at Alnylam Pharmaceuticals, where she advanced from Manager to Senior Director in Business Development. She began her professional journey in investment banking with Goldman Sachs, focusing on healthcare advisory. Caitlin holds an MBA from Columbia Business School and a BA in Mathematics from Bowdoin College. Her analytical skills and strategic mindset enable her to navigate complex business landscapes effectively. Outside of her professional endeavors, Caitlin is passionate about leveraging innovation to improve healthcare outcomes.
Caitlin Mevorach Cooper
Work Experience
VP, Head of Business Development at
Generation Bio
October 2021 - Present
Senior Director, Business Development at
Alnylam Pharmaceuticals
January 2021 - October 2021
Director, Business Development at
Alnylam Pharmaceuticals
February 2019 - January 2021
Associate Director, Business Development at
Alnylam Pharmaceuticals
July 2017 - February 2019
Senior Manager, Business Development at
Alnylam Pharmaceuticals
July 2016 - July 2017
Manager, Business Development at
Alnylam Pharmaceuticals
October 2015 - July 2016
Investment Banking Associate at
Goldman Sachs
July 2014 - September 2015
Summer Investment Banking Associate at
Goldman Sachs
January 2013 - January 2013
Product Management at
Amwell
January 2012 - January 2012
Consultant, Strategy and Operations at
Deloitte
January 2009 - January 2012
Caitlin Mevorach Cooper
Education
Bowdoin College, Ba
Columbia Business School, Master Of Business Administration (Mba)
Frequently Asked Questions about Caitlin Mevorach Cooper
What is Caitlin Mevorach Cooper email address?
Caitlin Mevorach Cooper's primary email address is *******@generationbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Caitlin Mevorach Cooper work for?
Caitlin Mevorach Cooper is a VP, Head of Business Development at Generation Bio, a company specializing in Commercial physical research.
Where Caitlin Mevorach Cooper graduated from?
Caitlin Mevorach Cooper holds a degree in Mathematics from Bowdoin College.
How can I directly contact Caitlin Mevorach Cooper?
To contact Caitlin Mevorach Cooper directly, you can use the email address *******@generationbio.com. Complete contact information is available upon registration with Muraena.
Who is Caitlin Mevorach Cooper?
Caitlin Mevorach Cooper is a seasoned business development professional with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as VP and Head of Business Development at Generation Bio, she has a proven track record in strategic business initiatives, financial analysis, and product management. Caitlin's career includes significant roles at Alnylam Pharmaceuticals, where she advanced from Manager to Senior Director in Business Development. She began her professional journey in investment banking with Goldman Sachs, focusing on healthcare advisory. Caitlin holds an MBA from Columbia Business School and a BA in Mathematics from Bowdoin College. Her analytical skills and strategic mindset enable her to navigate complex business landscapes effectively. Outside of her professional endeavors, Caitlin is passionate about leveraging innovation to improve healthcare outcomes.
Caitlin`s contact details
*******@generationbio.com
Colleagues
Vice President of Molecular Biology
Director
VP, Head of Intellectual Property
VP Portfolio strategy & Alliance management
SVP Preclinical Research
VP, Corporate & Securities Law and Asst. Secretary
Chief Operating Officer
VP, Head of Delivery
Vice President, Translational Biology
VP of Finance